ArticleFrontiers in public health2024
The library is open: a scoping review on queer representation in psychedelic research.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization.Frontiers in psychiatry · 2026Article
- Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.Psychological medicine · 2025Article
- Naturalistic psychedelic experiences and gender-based self-acceptance in transgender and gender-expansive people.International journal of transgender health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The intersection of queer identity and psychedelics has not been thoroughly explored by the research community, historically or in the present day. With growing access to legal psychedelic therapies, it is essential that queer psychedelic experiences are understood sufficiently by clinicians in order to provide the most safe and effective care possible. Psychedelics and queerness are intricately related, and there is strong interest in the use of psychedelics for healing and identity development among queer populations. However, the vast majority of the literature stigmatizes and problematizes queer psychedelic use. Therefore this scoping review seeks to explore the current and historical overlap between psychedelics and queerness in the academic literature. Specifically, this scoping review aims to understand the available academic literatures' treatment of the meaningful, non-pathologizing use of psychedelics within the queer community, and seeks to highlight the unique potential a queer lens and the queer experience can bring to the study of psychedelics. To do so, we asked what queer psychedelic experiences are reflected in the literature, who is being studied, what queer individuals' motivations are for using psychedelics, and a review of the impacts of queer psychedelic use discussed in the literature. Literature searches were performed in seven academic databases using a wide breadth of both queer-related and psychedelic-related keywords, which resulted in over thirty thousand resources being captured. After screening, a total of 18 resources were collected as representative of the meaningful overlap of psychedelics and queerness. Based on the findings and research gaps identified, this scoping review makes several recommendations regarding future directions psychedelic researchers and clinicians can pursue to better understand and benefit from the meaningful overlap of psychedelics and queerness. By reclaiming, redefining, and reimagining the meaningful relationship between psychedelics and the queer experience, this review helps move the scientific and clinical conversation into queerer spaces, centering queerness and queer experiences as an essential component of psychedelic research and practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.